6s6w - Revision history

OCA at 12:36, 24 January 2024

2024-01-24T12:36:19Z

←Older revision		Revision as of 12:36, 24 January 2024
Line 3:		Line 3:
	<StructureSection load='6s6w' size='340' side='right'caption='[[6s6w]], [[Resolution\|resolution]] 3.25Å' scene=''>		<StructureSection load='6s6w' size='340' side='right'caption='[[6s6w]], [[Resolution\|resolution]] 3.25Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6s6w]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S6W OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=6S6W FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6s6w]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S6W OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6S6W FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat" id="~~ligandDat~~">~~<scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>~~, ~~<scene name='pdbligand=KXT:2,6-diphenylimidazo~~[~~1,2-a~~]~~pyridine'>KXT</scene>, <scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 3.25Å</td></tr>
-	<tr id='~~gene~~'><td class="sblockLbl"><b>[[~~Gene~~\|~~Gene~~:]]</b></td><td class="sblockDat"~~>ALDH1A3, ALDH6 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&~~id=~~9606 HUMAN])</td~~><~~/tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=KXT:2,6-diphenylimidazo[1,2-a]pyridine'>KXT</scene>, <scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr>
-	~~<tr id~~='~~activity'><td class~~=~~"sblockLbl"><b>Activity~~:~~</b~~></td><~~td class~~=~~"sblockDat"><span class~~=~~'plainlinks'>[http~~:~~//en.wikipedia.org/wiki/Retinal_dehydrogenase Retinal dehydrogenase]~~, ~~with EC number~~ [~~http://www.brenda-enzymes.info/php/result_flat.php4?ecno=~~1.2~~.1.36 1.2.1.36~~] </~~span~~></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6s6w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s6w OCA], [https://pdbe.org/6s6w PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6s6w RCSB], [https://www.ebi.ac.uk/pdbsum/6s6w PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6s6w ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6s6w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s6w OCA], [~~http~~://pdbe.org/6s6w PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6s6w RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6s6w PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6s6w ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/AL1A3_HUMAN AL1A3_HUMAN]] Isolated anophthalmia - microphthalmia. The disease is caused by mutations affecting the gene represented in this entry.	+	[https://www.uniprot.org/uniprot/AL1A3_HUMAN AL1A3_HUMAN] Isolated anophthalmia - microphthalmia. The disease is caused by mutations affecting the gene represented in this entry.
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/AL1A3_HUMAN AL1A3_HUMAN]] Recognizes as substrates free retinal and cellular retinol-binding protein-bound retinal. Seems to be the key enzyme in the formation of an RA gradient along the dorso-ventral axis during the early eye development and also in the development of the olfactory system (By similarity).	+	[https://www.uniprot.org/uniprot/AL1A3_HUMAN AL1A3_HUMAN] Recognizes as substrates free retinal and cellular retinol-binding protein-bound retinal. Seems to be the key enzyme in the formation of an RA gradient along the dorso-ventral axis during the early eye development and also in the development of the olfactory system (By similarity).
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 22:		Line 21:
	</div>		</div>
	<div class="pdbe-citations 6s6w" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 6s6w" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Aldehyde dehydrogenase 3D structures\|Aldehyde dehydrogenase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	~~[[Category: Retinal dehydrogenase]]~~	+	[[Category: Ferraris DM]]
-	[[Category: Ferraris~~, D M~~]]	+	[[Category: Garavaglia S]]
-	[[Category: Garavaglia, S]]	+	[[Category: Gelardi ELM]]
-	[[Category: Gelardi~~, E L.M~~]]	+	[[Category: LaMotta C]]
-	[[Category: LaMotta, C]]	+	[[Category: Quattrini L]]
-	[[Category: Quattrini, L]]	+
-	~~[[Category: Aldh1a3 ga11 glioma 2]]~~	+
-	~~[[Category: Cytosolic protein~~]]	+

OCA at 07:26, 27 May 2020

2020-05-27T07:26:56Z

←Older revision		Revision as of 07:26, 27 May 2020
Line 1:		Line 1:

	==Crystal Structure of human ALDH1A3 in complex with 2,6-diphenylimidazo[1,2-a]pyridine (compound GA11) and NAD+==		==Crystal Structure of human ALDH1A3 in complex with 2,6-diphenylimidazo[1,2-a]pyridine (compound GA11) and NAD+==
-	<StructureSection load='6s6w' size='340' side='right'caption='[[6s6w]]' scene=''>	+	<StructureSection load='6s6w' size='340' side='right'caption='[[6s6w]], [[Resolution\|resolution]] 3.25Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S6W OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6S6W FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6s6w]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S6W OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6S6W FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6s6w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s6w OCA], [http://pdbe.org/6s6w PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6s6w RCSB], [http://www.ebi.ac.uk/pdbsum/6s6w PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6s6w ProSAT]</span></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=KXT:2,6-diphenylimidazo[1,2-a]pyridine'>KXT</scene>, <scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">ALDH1A3, ALDH6 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Retinal_dehydrogenase Retinal dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.2.1.36 1.2.1.36] </span></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6s6w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s6w OCA], [http://pdbe.org/6s6w PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6s6w RCSB], [http://www.ebi.ac.uk/pdbsum/6s6w PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6s6w ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/AL1A3_HUMAN AL1A3_HUMAN]] Isolated anophthalmia - microphthalmia. The disease is caused by mutations affecting the gene represented in this entry.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/AL1A3_HUMAN AL1A3_HUMAN]] Recognizes as substrates free retinal and cellular retinol-binding protein-bound retinal. Seems to be the key enzyme in the formation of an RA gradient along the dorso-ventral axis during the early eye development and also in the development of the olfactory system (By similarity).
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Glioblastoma multiforme (GBM) is the deadliest form of brain tumor. It is known for its ability to escape the therapeutic options available to date thanks to the presence of a subset of cells endowed with stem-like properties and ability to resist to cytotoxic treatments. As the cytosolic enzyme aldehyde dehydrogenase 1A3 turns out to be overexpressed in these kinds of cells, playing a key role for their vitality, treatments targeting this enzyme may represent a successful strategy to fight GBM. In this work, we describe a novel class of imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase 1A3 inhibitors, reporting the evidence of their significance as novel drug candidates for the treatment of GBM. Besides showing an interesting functional profile, in terms of activity against the target enzyme and selectivity toward highly homologous isoenzymes, representative examples of the series also showed a nanomolar to picomolar efficacy against patient-derived GBM stem-like cells, thus proving the concept that targeting aldehyde dehydrogenase might represent a novel and promising way to combat GBM by striking its ability to divide immortally.
		+
		+	Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.,Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C J Med Chem. 2020 Apr 20. doi: 10.1021/acs.jmedchem.9b01910. PMID:32223240<ref>PMID:32223240</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6s6w" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Ferraris DM]]	+	[[Category: Retinal dehydrogenase]]
-	[[Category: Garavaglia S]]	+	[[Category: Ferraris, D M]]
-	[[Category: Gelardi ~~ELM~~]]	+	[[Category: Garavaglia, S]]
-	[[Category: LaMotta C]]	+	[[Category: Gelardi, E L.M]]
-	[[Category: Quattrini L]]	+	[[Category: LaMotta, C]]
		+	[[Category: Quattrini, L]]
		+	[[Category: Aldh1a3 ga11 glioma 2]]
		+	[[Category: Cytosolic protein]]

OCA at 05:42, 22 April 2020

2020-04-22T05:42:41Z

←Older revision		Revision as of 05:42, 22 April 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6s6w is ~~ON HOLD until Paper Publication~~	+	==Crystal Structure of human ALDH1A3 in complex with 2,6-diphenylimidazo[1,2-a]pyridine (compound GA11) and NAD+==
-		+	<StructureSection load='6s6w' size='340' side='right'caption='[[6s6w]]' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S6W OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6S6W FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6s6w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s6w OCA], [http://pdbe.org/6s6w PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6s6w RCSB], [http://www.ebi.ac.uk/pdbsum/6s6w PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6s6w ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Ferraris DM]]
		+	[[Category: Garavaglia S]]
		+	[[Category: Gelardi ELM]]
		+	[[Category: LaMotta C]]
		+	[[Category: Quattrini L]]

OCA at 04:26, 7 August 2019

2019-08-07T04:26:46Z

←Older revision		Revision as of 04:26, 7 August 2019
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6s6w is ON HOLD	+	The entry 6s6w is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "6s6w" [edit=sysop:move=sysop]

2019-07-10T04:29:11Z

Protected "6s6w" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:29, 10 July 2019

OCA: New page: '''Unreleased structure''' The entry 6s6w is ON HOLD Authors: Description: Category: Unreleased Structures

2019-07-10T04:29:09Z

New page: '''Unreleased structure''' The entry 6s6w is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 6s6w is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]